Department of Pharmaceutical Chemistry, Era College of Pharmacy, Era University, Lucknow, 226003, Uttar Pradesh, India.
10.21608/jpac.2023.301119
Abstract
Abstract: Tuberculosis remains the leading cause of mortality worldwide. The second line of anti-TB drug Nucleoside analogs has been introduced in several compounds to improve their anti-TB activity against mycobacterium as well as their multidrug-resistant strains. Several Nucleoside analogs have shown very good activity. A series of Nucleoside analogs have been evaluated for their activity against M. tuberculosis. Some Nucleoside analogs exhibited significant activity when compared with first-line drugs and could be a good starting point to develop new lead compounds in the fight against multi-drug resistant tuberculosis.
M., A. (2023). Role of Nucleoside and Macrolides Analogs in the Treatment of Infectious Disease Tuberculosis: A Short Review. Journal of Pharmaceutical and Applied Chemistry, 9(2), 7-11. doi: 10.21608/jpac.2023.301119
MLA
Asif M.. "Role of Nucleoside and Macrolides Analogs in the Treatment of Infectious Disease Tuberculosis: A Short Review". Journal of Pharmaceutical and Applied Chemistry, 9, 2, 2023, 7-11. doi: 10.21608/jpac.2023.301119
HARVARD
M., A. (2023). 'Role of Nucleoside and Macrolides Analogs in the Treatment of Infectious Disease Tuberculosis: A Short Review', Journal of Pharmaceutical and Applied Chemistry, 9(2), pp. 7-11. doi: 10.21608/jpac.2023.301119
VANCOUVER
M., A. Role of Nucleoside and Macrolides Analogs in the Treatment of Infectious Disease Tuberculosis: A Short Review. Journal of Pharmaceutical and Applied Chemistry, 2023; 9(2): 7-11. doi: 10.21608/jpac.2023.301119
)
View on SCiNiTO